A review of recent FDA-approved biologic-device combination products
1. 请及时下载文件确认是否正确, 系统将在 2026-01-20 14:38:52 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
J Guo, J Weng, Q Zhu, F Zhou, Q Chen, X Gu…
Journal of …, 2024
Elsevier
With the remarkably strong growth of the biopharmaceutical market, an increasing demand for self-administration and rising competitions attract substantial interest to the biologic-device combination products. The ease-of-use of biologic-device combination products can minimize dosing error, improve patient compliance and add value to the life-cycle management of biological products. As listed in the purple book issued by the US Food and Drug Administration (FDA), a total of 98 brand biologic-device combination products have …
